Publication | Closed Access

Outcomes, dosing, and predictors of vedolizumab treatment in children with inflammatory bowel disease (VEDOKIDS): a prospective, multicentre cohort study

Vedolizumab TreatmentMulticentre Cohort StudyClinical EpidemiologyGastroenterologyPediatricsPediatric GastroenterologyClinical GastroenterologyUlcerative ColitisMedicineSystemic Juvenile Idiopathic Arthritis